Literature DB >> 20177958

Impaired pneumovax-23-induced monocyte-derived cytokine production in patients with common variable immunodeficiency.

Raymond Hong1, Sudhanshu Agrawal, Sastry Gollapudi, Sudhir Gupta.   

Abstract

INTRODUCTION: Streptococcus pneumoniae is one of the most common infectious pathogens in common variable immunodeficiency (CVID). Both innate and adaptive immune response appears to play a role in defense against S. pneumoniae. In mice, it has been established that TLR2 and macrophages-derived cytokines (IL-6, TNF-alpha) play a crucial role in defense against S. pneumoniae. In humans, monocyte/macrophage-derived cytokines in response to S. pneumoniae have not been studied. Patients with CVID respond poorly to Pneumovax-23 (containing all capsular polysaccharides) vaccination.
FINDINGS: In this study, we show that Pneumovax-23, in a concentration and time-dependent manner, induced secretion of IL-6, IL-10, and TNF-alpha by monocytes and not by B cells or T cells from healthy controls. Furthermore, Pneumovax-23-induced secretion of IL-6 and TNF-alpha was significantly less in patients with CVID as compared with controls. In addition, Pneumovax-23-induced upregulation of TLR2 in all four subsets of monocytes; however, differences between control and CVID were not significant.
CONCLUSION: Pneumovax-23-induced monocytes-derived cytokine production is impaired in CVID, which may play an important role in increased susceptibility of CVID patients to S. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177958     DOI: 10.1007/s10875-010-9371-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  29 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands.

Authors:  Goutam Sen; Abdul Q Khan; Quanyi Chen; Clifford M Snapper
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

Review 3.  Molecular defects in T- and B-cell primary immunodeficiency diseases.

Authors:  Charlotte Cunningham-Rundles; Prashant P Ponda
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

Review 4.  TLR signaling.

Authors:  T Kawai; S Akira
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

5.  Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection.

Authors:  Alison R Kerr; June J Irvine; Jennifer J Search; Neill A Gingles; Aras Kadioglu; Peter W Andrew; William L McPheat; Charles G Booth; Tim J Mitchell
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.

Authors:  E Lorenz; J P Mira; K L Cornish; N C Arbour; D A Schwartz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

7.  Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4.

Authors:  Matthias Klein; Bianca Obermaier; Barbara Angele; Hans-Walter Pfister; Hermann Wagner; Uwe Koedel; Carsten J Kirschning
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

8.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

9.  Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.

Authors:  D P O'Brien; D E Briles; A J Szalai; A H Tu; I Sanz; M H Nahm
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 10.  Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

Authors:  C Bacchelli; S Buckridge; A J Thrasher; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2007-09       Impact factor: 4.330

View more
  4 in total

Review 1.  Common Variable Immunodeficiency.

Authors:  Biman Saikia; Sudhir Gupta
Journal:  Indian J Pediatr       Date:  2016-02-12       Impact factor: 1.967

Review 2.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

3.  Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.

Authors:  Matthieu Perreau; Selena Vigano; Florence Bellanger; Céline Pellaton; Guillaume Buss; Denis Comte; Thierry Roger; Christine Lacabaratz; Pierre-Alexandre Bart; Yves Levy; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2014-09-15       Impact factor: 14.307

4.  Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax®23.

Authors:  Alena Roth; Stephanie Glaesener; Katharina Schütz; Almut Meyer-Bahlburg
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.